Clinical trial
ITI-007 (Lumateperone Tosylate) for Schizophrenia
NCT03817528
Study timeline
Study start (actual)2019-03-01Date precision: day
Registry last updated2021-11-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
ITI-007DRUG
Sponsors & collaborators
New York State Psychiatric Institutelead sponsor
Intra-Cellular Therapies, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03817528 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.